About this trial
StromaForte injection for knee OA
Eligibility criteria
Qualifiers
Willing and able to provide written informed consent and comply with all procedures required by the protocol.
Aged ≥ 18 years at the time of signing the informed consent form.
Diagnosed with knee osteoarthritis (OA) based on the criteria established by the American College of Rheumatology, confirmed through radiological images no older than three months.
Grade I to IV osteoarthritis on the Kellgren-Lawrence radiological classification scale.
Disqualifiers
Unwilling or unable to perform any of the assessments required by the protocol.
Mechanically unstable knee due to the presence of a complete anterior cruciate ligament, posterior cruciate ligament, medial collateral ligament and/or posterolateral corner tear.
Varus or valgus malalignment >5 degrees as measured by 4-foot standing antero-posterior radiographs.
History of subtotal medial or lateral meniscectomy performed less than 9 months ago.
Trial design
Treatments tested in this trial
- Mesenchymal Stem Cells (MSC)
- Hyaluronic Acid (HA)